A bifunctional dimethylsulfoxide substitute enhances the aqueous solubility of small organic molecules

Assay and Drug Development Technologies

Volumn 10, Issue 3, 2012, Pages 269-277

  Sprachman, Melissa M ^a   Wipf, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' SULFINYLBIS(METHYLENE)BIS(3 METHYLOXETANE); CARBENDAZIM; DIMETHYL SULFOXIDE; ESTRONE; GRISEOFULVIN; ORGANIC COMPOUND; PROTEIN KINASE D; QUININE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTEMIA; ARTICLE; BIOASSAY; CELL ASSAY; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; NONHUMAN; PH MEASUREMENT; SCREENING TEST; SOLUBILITY; SYNTHESIS; TOXICITY TESTING; WATER ABSORPTION;

ANIMALS; CELL LINE; DIMETHYL SULFOXIDE; HUMANS; LIVER; ORGANIC CHEMICALS; SOLUBILITY; SOLVENTS; WATER;

EID: 84862283099     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.0421     Document Type: Article

References (32)

1. Janzen WP, Popa-Burke IG: Advances in improving the quality and flexibility of compound management.J Biomol Screen 2009;14:444-451.
2. Waybright TJ, Britt JR, McCloud TG: Overcoming problems of compound storage in DMSO: solvent and process alternatives.J Biomol Screen 2009;14:708-715.
3. Talaga P: Compound decomposition: a new drug discovery tool? Drug Discov Today 2004;9:51-53.
4. Kozikowski BA, Burt TM, Tirey DA, et al.: The effect of room-temperature storage on the stability of compounds in DMSO.J Biomol Screen 2003;8:205-209.
5. Stegemann S, Leveiller F, Franchi D, de Jong H, Lindén H: When poor solubility becomes an issue: from early stage to proof of concept.Eur J Pharm Sci 2007;31:249-261.
6. Di L, Kerns EH: Application of pharmaceutical profiling assays for optimization of drug-like properties.Curr Opin Drug Discov Devel 2005;8:495-504.
7. Yalkowsky SH: Solubility and Solubilization in Aqueous Media.Oxford University Press, New York, 1999.
8. Strickley RG: Solubilizing excipients in oral and injectable formulations.Pharm Res 2004;21:201-230.
9. Oda M, Saitoh H, Kobayashi M, Aungst BJ: b-Cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs.Int J Pharm 2004;280:95-102.
10. Ouyang L, Ma L, Jiang B, Li Y, He D, Guo L: Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.Eur J Med Chem 2010;45:2705-2711.
11. Sanghvi R, Narazaki R, Machatha SG, Yalkowsky SH: Solubility improvement of drugs using N-methyl pyrrolidone.AAPS PharmSciTech 2008;9:366-376.
12. Pitha J, Szente A, Greenberg J: Poly-L-methionine sulfoxide: a biologically inert analogue of dimethyl sulfoxide with solubilizing potency.J Pharm Sci 1983;72:665-668.
13. Rose NG, Blaskovich MA, Evindar G, et al.: Preparation of 1-[N-benzyloxycarbonyl- (1S)-1-amino-2-oxoethyl]-4-methyl-2,6,7-trioxabicyclo[2. 2.2]octane.Org Synth 2002;79:216-221.
14. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL: Brine shrimp: a convenient general bioassay for active plant constituents.Planta Med 1982;45:31-34.
15. Zhdanko AG, Nenajdenko VG: Nonracemizable isocyanoacetates for multicomponent reactions.J Org Chem 2009;74:884-887.
16. Bellon L, Taft RW, Abboud JM: Structural effects on the reactivity of ethers in donor-acceptor reactions.J Org Chem 1980;45:1166-1168.
17. Wuitschik G, Carreira EM, Wagner B, et al.: Oxetanes in drug discovery: structural and synthetic insights.J Med Chem 2010;53:3227-3246.
18. Kurien BT, Singh A, Matsumoto H, Scofield RH: Improving the solubility and pharmacological efficacy of curcumin by heat treatment.Assay Drug Dev Technol 2007;5:567-576.
19. Yu X, Li Y, Wu D: Enzymatic synthesis of gallic acid esters using microencapsulated tannase: effect of organic solvents and enzyme specificity.J Mol Catal-B Enzym 2004;30:69-73.
20. Yalkowsky SH, He Y: Handbook of Aqueous Solubility Data.CRC Press, New York, 2003.
21. Shareef A, Angove MJ, Wells JD, Johnson BB: Aqueous solubilities of estrone, 17b-estradiol, 17a-ethynylestradiol, and bisphenol A.J Chem Eng Data 2006;51:879-881.
22. BioFocus.Available at: http://biofocus.com/offerings/adme-pk-laboratory/ solubility (last accessed: September 21, 2011).
23. Bravo-Altamirano K, George KM, Frantz MC, et al.: Synthesis and structureactivity relationships of benzothienothiazepinone inhibitors of protein kinase D.ACS Med Chem Lett 2011;2:154-159.
24. George KM, Frantz MC, Bravo-Altamirano K, et al.: Design, synthesis, and biological evaluation of PKD inhibitors.Pharmaceutics 2011;3:186-228.
25. Sharlow ER, Giridhar KV, LaValle CR, et al.: Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.J Biol Chem 2008;283:33516-33526.
26. Eigenmann HK, Golden DM, Benson SW: Revised group additivity parameters for the enthalpies of formation of oxygen-containing organic compounds.J Phys Chem 1973;77:1687-1691.
27. Banks HD: A computational study to elucidate the extraordinary reactivity of three-membered heterocycles in nucleophilic substitution reactions.J Org Chem 2003;68:2639-2644.
28. Druckrey H, Kruse H, Preussmann R, Ivankovic S: Cancerogene Alkylierende Substanzen.Z Krebsforsch 1970;74:241-273.
29. Dickens F, Jones HE: Further studies on the carcinogenic and growthinhibitory activity of lactones and related substances.Br J Cancer 1963;17: 100-108.
30. Gómez-Bombarelli R, Palma BB, Martins C, et al.: Alkylating potential of oxetanes.Chem Res Toxicol 2010;23:1275-1281.
31. Uch AS, Hesse U, Dressman JB: Use of 1-methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs.Pharm Res 1999;16:968-971.
32. Cheng X, Hochlowski J, Tang H, et al.: Studies on repository compound stability in DMSO under various conditions.J Biomol Screen 2003;8:292-304.